ANGELIA CASTEEL: Open Payments
NPI 1154097863 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,364 in 92 payments from 25 companies in 2025. Trend: 2023 $109 · 2024 $446 · 2025 $2,364
Food & beverage: $2,364
| Company | Payments | Amount |
|---|---|---|
| SANOFI-AVENTIS U.S. LLC | 6 | $312 |
| Novo Nordisk Inc | 8 | $236 |
| Xeris Pharmaceuticals, Inc. | 8 | $236 |
| Tandem Diabetes Care, Inc. | 5 | $201 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $157 |
| Sequel Med Tech, LLC | 8 | $154 |
| BETA BIONICS, INC. | 5 | $149 |
| Mannkind Corporation | 7 | $144 |
| Lilly USA, LLC | 8 | $126 |
| RECORDATI_RARE_DISEASES_INC. | 4 | $105 |
Products named: TZIELD, t:slim X2 Insulin Pump with Control-IQ, GVOKE HYPOPEN, Ozempic, JARDIANCE, TWIIST, iLet Bionic Pancreas, AFREZZA.
Industry payments across OK — which companies pay providers there.
